Table 1.

COVID 19 present medications and cardiovascular system

Medications	Cardiovascular effects
Antivirals	Direct myocardial toxicity; Prolonged QTc, AV blocks, Torsades de pointes, Interaction with antiarrhythmics
Chloroquine and Hydroxychloroquine	Direct myocardial toxicity; Worsen cardiomyopathy; Bundle branch block; AV block; Ventricular arrhythmias; Torsades de pointes; Prolonged QTc
Azithromycin	Dysrhythmias; Prolonged QTc; Torsades de pointes
Corticosteroids	Fluid retention; Hypertension, Electrolyte changes
Tocilizumab	Hypertension